MedPath

Preparing FIM-BCS - A Lifestyle Modification for African-American Breast Cancer Survivors

Not Applicable
Suspended
Conditions
Nutrition, Healthy
Hypertension
Obesity
Registration Number
NCT06504914
Lead Sponsor
University of Illinois at Chicago
Brief Summary

Hypertension and obesity are both major risk factors for cardiovascular disease (CVD), a leading cause of death for Black women in the United States. The investigators propose examining the feasibility and acceptability of the 12-week RN-CHeFRx (Real Nourishment and Cooking Healthy Food is Rx) intervention

\- grocery delivery, cooking classes, and nutrition education - for Black women with hypertension and obesity to improve nutritious eating habits and blood pressure control.

Detailed Description

The objective of this study is to conduct the RN-CHeFRx (Real Nourishment and Cooking Healthy Food is Rx) for 12 weeks among Black women who are obese and hypertensive living Chicago. We propose to 1) Pilot the RN-CHEFRx intervention and measures that will be used to assess blood pressure, BMI status, and sodium intake with 20 Black women diagnosed with hypertension and BMI ≥ 30. We will assess the efficacy of the evaluation tools to be used in a future clinical trial at three-time points (baseline, 12 weeks, and 6 months); and 2) Assess the feasibility and acceptability of the RN-CHeFRx intervention using interviews, surveys, and documentary analysis. Findings from this study will inform a larger efficacy trial of RN-CHeFRx to improve dietary behaviors and blood pressure control among Black women with hypertension and obesity

Recruitment & Eligibility

Status
SUSPENDED
Sex
Female
Target Recruitment
24
Inclusion Criteria
  • self-identified as Black or of African descent
  • female
  • ≥ 18 years old
  • baseline blood pressure ≥130/85 or diagnosed with hypertension and BMI ≥ 30
Exclusion Criteria
  • inability to cook in their homes
  • cognitive deficits impeding the ability to participate or provide informed consent
  • current treatment for cancer
  • liver or renal disease
  • pregnancy
  • lack of English language proficiency

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Number of participants who complete the 12 week intervention[Time Frame: Up to 12 weeks]

Completion will be measured by class attendance

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Illinois Chicago

🇺🇸

Chicago, Illinois, United States

University of Illinois Chicago
🇺🇸Chicago, Illinois, United States
Principal Investigator
Contact
312-355-2125
slofto4@uic.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.